Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

University of Rochester Medical Center, Rochester

University of Pennsylvania, Philadelphia

Virginia Commonwealth University, Richmond

Duke University, Durham

Rare Disease Research, Atlanta

University of Florida, Gainesville

Ohio State University, Columbus

Kansas University Medical Center, Kansas City

University of Texas Southwestern, Dallas

University of Colorado, Denver

University of California Los Angeles, Los Angeles

University of California San Diego, San Diego

Stanford University, Palo Alto

University of Washington, Seattle

University of Ottawa, Ottawa

University College London, London

University of Sheffield, Sheffield